Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reilly

Showing results (51-60 of 318) with videos related to

Pageof 32
Sort By:
The Journal of Biological Chemistry|August 25, 1992
Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolutionC F Reilly, J E Hutzelmann
The Journal of Cell Biology|March 21, 2001
Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferationJ F Reilly, P A Maher
The American Journal of the Medical Sciences|December 9, 2010
Imaging patients with kidney disease: how do we approach contrast-related toxicity?Mark A Perazella, Robert F Reilly
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?Jeffrey G Penfield, Robert F Reilly
Experimental Neurology|August 1, 1996
Alterations in fibroblast growth factor receptor expression following brain injuryJ F Reilly, V G Kumari
Seminars in Dialysis|November 3, 2010
Unfractionated heparin for hemodialysis: still the best optionRobert E Cronin, Robert F Reilly
Critical Care Medicine|November 21, 1998
Interpreting the anion gapR F Reilly, R J Anderson
Connecticut Medicine|November 27, 2002
Chronic kidney disease: a new approach to an old problemRobert F Reilly, Mark A Perazella
Pediatric Blood & Cancer|September 25, 2004
Atypical mycobacterial infections in children with cancerAnne F Reilly, Karin L McGowan
Gastroenterology Clinics of North America|December 1, 1991
Palliative treatment of esophageal carcinoma using laser and tumor probe therapyH F Reilly, D E Fleischer
Pageof 32

Showing results (51-60 of 318) with videos related to

Sort By:
Pageof 32
The Journal of Biological Chemistry|August 25, 1992
Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolutionC F Reilly, J E Hutzelmann
The Journal of Cell Biology|March 21, 2001
Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferationJ F Reilly, P A Maher
The American Journal of the Medical Sciences|December 9, 2010
Imaging patients with kidney disease: how do we approach contrast-related toxicity?Mark A Perazella, Robert F Reilly
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?Jeffrey G Penfield, Robert F Reilly
Experimental Neurology|August 1, 1996
Alterations in fibroblast growth factor receptor expression following brain injuryJ F Reilly, V G Kumari
Seminars in Dialysis|November 3, 2010
Unfractionated heparin for hemodialysis: still the best optionRobert E Cronin, Robert F Reilly
Critical Care Medicine|November 21, 1998
Interpreting the anion gapR F Reilly, R J Anderson
Connecticut Medicine|November 27, 2002
Chronic kidney disease: a new approach to an old problemRobert F Reilly, Mark A Perazella
Pediatric Blood & Cancer|September 25, 2004
Atypical mycobacterial infections in children with cancerAnne F Reilly, Karin L McGowan
Gastroenterology Clinics of North America|December 1, 1991
Palliative treatment of esophageal carcinoma using laser and tumor probe therapyH F Reilly, D E Fleischer
Pageof 32